Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Other Liabilities

Arbutus Biopharma Cp Other Liabilities Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Other Liabilities from 2010 to 2018.
  • Arbutus Biopharma Cp Other Liabilities for the quarter ending December 12, 2018 was $17m a -61.02% decrease of -10m year over year
  • Arbutus Biopharma Cp Other Liabilities for the last 12 months ending December 12, 2018 was $17m a -61.02% decrease of -10m year over year
  • Arbutus Biopharma Cp Annual Other Liabilities for 2018 was $17m a -89.35% decrease of -15m from 2017
  • Arbutus Biopharma Cp Annual Other Liabilities for 2017 was $32m a -57.28% decrease of -18m from 2016
  • Arbutus Biopharma Cp Annual Other Liabilities for 2016 was $50m a -206.06% decrease of -104m from 2015
Other Balance Sheet Metrics:
  • Arbutus Biopharma Cp Total Assets for the quarter ending December 12, 2018 was $228m a -18.48% decrease of -42m year over year
  • Arbutus Biopharma Cp Total Equity for the quarter ending December 12, 2018 was $200m a -16.09% decrease of -32m year over year
View Chart On Koyfin

Quarterly ABUS Other Liabilities Data

12/2018$17m
09/2018$17m
06/2018$28m
03/2018$27m
12/2017$28m
09/2017$52m
06/2017$55m
03/2017$56m
12/2016$50m
09/2016$90m

Annual ABUS Other Liabilities Data

2018$17m
2017$32m
2016$50m
2015$154m
2014$10m
2012$1m
2011$2m
2010$2m